Australia's most trusted
source of pharma news
Friday, 24 July 2026
Posted 24 July 2026 AM
Melbourne-based pharma Clinuvel has announced a major restructure, including job losses and a relocation of its headquarters.
The company has announced plans to cut its global workforce by 10-20 per cent, concurrent with the relocation of its corporate headquarters from Melbourne to the United States. It currently has a US operational office in Burlingame, near San Francisco.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.